Tech Company Financing Transactions
ImpactRx Funding Round
On 8/23/2004, ImpactRx announced $14.3 million in Series D investment from 3i Venture Capital, Mediphase Venture Partners and Merck Capital Ventures.
Transaction Overview
Company Name
Announced On
8/23/2004
Transaction Type
Venture Equity
Amount
$14,300,000
Round
Series D
Investors
Proceeds Purpose
The funding will enable the company to expand current product offerings and to develop international initiatives.
Company Information
Company Status
Acquired or Merged
Industry
Enterprise IT
Mailing Address
220 Gibraltar Rd 200
Horsham, PA 19044
USA
Horsham, PA 19044
USA
Phone
Website
Email Address
Overview
ImpactRx comprehensively collects data on promotion and physician treatment decisions for every pharmaceutical product currently marketed in the United States from its exclusive network of high prescribing physicians.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Ellis
VP - Bus. Development
Robert Delghiaccio
VP - Client Services
Tom Principe
VP - Finance
Jina Melnyk
VP - Marketing
Patrick Angelastro
VP - Operations
Anand Narasimhan
Browse more venture capital transactions:
Prev: 8/23/2004: July Systems venture capital transaction
Next: 8/25/2004: Vonage Holdings venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs